Download
document (28).pdf 630,56KB
WeightNameValue
1000 Titel
  • Use of Digital Image Analysis for Outcome Prediction in Breast Cancer
1000 Autor/in
  1. Roxanis, I. |
  2. Colling, R. |
1000 Erscheinungsjahr 2016
1000 Publikationstyp
  1. Kongressschrift |
  2. Artikel |
1000 Online veröffentlicht
  • 2016-06-08
1000 Erschienen in
1000 Quellenangabe
  • 1(8):137
1000 Übergeordneter Kongress
1000 Copyrightjahr
  • 2016
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.17629/www.diagnosticpathology.eu-2016-8:137 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • INTRODUCTION / BACKGROUND: Breast cancer is the most common cancer in theUK. Although 10 year survival has increased over last decades, significant improvement is still needed. Clinical management decisions are largely dependent on assessment of histological features. The traditional approach to histopathological assessment has been the expert manual reporting of cases as viewed with a light microscope and has remained virtually unchanged since 1928, with minor modifications that have led to the current routinely applied semi-quantitative tumour grading system. However, the abundance of information within the tumour microenvironment is not reflected in the traditionally evaluated histological features, and there remain morphological features with prognostic potential that have previously been beyond investigation by traditional manual microscopic means. Tumour prognosis is closely related to metastasis, a complex process involving tumour cell migration through the stromal microenvironment before entering the lymphovascular compartment. Tumour/stromal interaction is crucial in the process and represents a potential candidate for therapeutic intervention. This interaction is partly affected by the pattern of tumour migration, revealed in the tumour architecture, and partly by the stromal response. AIMS: Our working hypothesis for the proposed study framework was that, with the application of digital image analysis technology, previously unquantifiable tumour architectural and microenvironmental features can be rigorously assessed in detail and tested as potential prognostic parameters. Quantified features included tumour extracellular particles at the tumour-stroma interface, tumour infiltrating lymphocytes, tumour nest perimeter, number, size and shape. The selected prognostic parameter was axillary lymph node metastasis. METHODS: Our initial study included diagnostic core biopsies from 19 HER2 positive breast cancers, with approximately equal number of ER strongly positive or weakly positive/ negative cases. Her2 immunohistochemistry allowed rigorous segregation of epithelial elements. Immunostained sections were digitised using a Hamamatsu scanner and x10 magnification consecutive segments from .ndpi files were captured as .jpeg files and analysed using Fiji (Image J), a public domain image processing program. The entirety of each core was examined in all cases. Several native Fiji Functions and Fiji plugins, including Trainable Weka Segmentation, Colour Segmentation and Colour Deconvolution were employed in different combinations for different types of analysis. The analysis is currently being expanded to a large set of digitised breast cancer tissue microarray (TMA) slides which have been stained with cytokeratin to highlight tumour cells. The set includes breast cancer cases from all molecular subtypes and is linked with detailed histological and outcome data. RESULTS: Increased number of extracellular particles at the tumour-stroma interface and decreased number of tumour-infiltrating lymphocytes were significantly associated with axillary lymph node metastasis (p=0.0062 and p=0.0154 respectively). Combination of the two parameters increased further the strength of the association (p=0.0011). Increased total tumour nest perimeter, tumour nest number and tumour nest shape irregularity were also significantly associated with axillary lymph node metastasis (p=0.0288, p=0.0085 and 0.0203 respectively). Data from the analysis of TMAs are currently analyzed and will be presented.
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/Um94YW5pcywgSS4=|https://frl.publisso.de/adhoc/uri/Q29sbGluZywgUi4=
1000 Label
1000 Förderer
  1. Verein für den biol. technol. Fortschritt in der Medizin, Heidelberg |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Verein für den biol. technol. Fortschritt in der Medizin, Heidelberg |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6431992.rdf
1000 Erstellt am 2022-03-04T18:53:14.876+0100
1000 Erstellt von 218
1000 beschreibt frl:6431992
1000 Bearbeitet von 218
1000 Zuletzt bearbeitet Thu Aug 18 13:06:50 CEST 2022
1000 Objekt bearb. Thu May 12 18:35:47 CEST 2022
1000 Vgl. frl:6431992
1000 Oai Id
  1. oai:frl.publisso.de:frl:6431992 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source